Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

NCT03640325

Conditions
Adherence, Medication, Adolescent Behavior, Anxiety, +20 more
Locations
  • University of Alabama, Birmingham Birmingham, Alabama, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Completed

Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation

NCT01915498

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations
  • City Of Hope Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami Sylvester Cancer Center Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

NCT03900715

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Local Institution - 338 Matsuyama, Ehime, Japan
  • Local Institution - 344 Nagasaki, Japan
  • Local Institution - 336 Sayama, Osaka, Japan
  • Local Institution - 345 Chiba, Japan
View all 19 locations
View Trial Details
Completed

Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

NCT04820530

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Tianjin, China
  • Novartis Investigative Site Tianjin, China
  • Novartis Investigative Site Paris, France
View Trial Details
Completed

Study of Efficacy and Safety of Twice Daily Oral LNP023 in Adult PNH Patients With Residual Anemia Despite Anti-C5 Antibody Treatment

NCT04558918

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • City Of Hope National Med Center City of Hope Medical Center Duarte, California, United States
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Augusta University Georgia Patient Treatment Augusta, Georgia, United States
  • Levine Cancer Insitute Carolinas Healthcare System Charlotte, North Carolina, United States
View all 39 locations
View Trial Details

Related conditions